ATOS · Atossa Therapeutics, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. These conditions raise substantial doubt as to the Company's ability to continue as a going concern. ... Although the Company received this infusion of capital, management maintains that in order to alleviate the conditions that raise substantial doubt, the Company will need, among other things, additional capital resources. ... However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans.”